Allergan Inc. (AGN) reported that its third-quarter net earnings attributable to stockholder were $179.0 million or $0.58 per share, compared to $165.4 million or $0.54 per share in the year ago quarter.
Non-GAAP earnings share attributable to stockholders were $215.4 million or $0.70, compared to $200.4 million or $0.65 per share in the third quarter of 2008. Analysts polled by Thomson Reuters expected the company to report earnings of $0.70 per share for the quarter. Analysts' estimates typically exclude special items.
Revenues for the quarter were $1.14 billion, compared to $1.10 billion in the prior year quarter. Sixteen analysts had consensus revenue estimate of $1.08 billion for the quarter.
Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on November 30, 2009 to stockholders of record on November 9, 2009.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.